Tag: Prescription Drugs
Novel Oral Glucose Lowering Drugs Cut Risks in T2DM
Reduced risk of all-cause mortality and CVD with dapagliflozin; lower risk of mortality with DPP-4i
30-day Mortality Down With Vancomycin in C. difficile
But Clostridium difficile recurrence rate similar for metronidazole, vancomycin
Variation in Prescribing Practices for Pediatric Atopic Dermatitis
For severe AD, first-line drugs of choice include cyclosporine, methotrexate, mycophenolate mofetil
Underuse, Misuse of Hormone Tx in Breast Cancer Still Occurring
Estimated 14,630 women not given recommended therapy died from cancer recurrence from 2004-2013
Psychostimulants May Be Helpful in Treatment of Bulimia Nervosa
Case reports highlight six outpatients with reduction in number of binge/purge days/month
Review: Cardiopulmonary Event Rate Not Up With Propofol Use
Similar risk with propofol versus traditional sedation for gastrointestinal endoscopic procedures
Very Low LDL-C Levels Well Tolerated With Alirocumab
No increase in treatment-emergent adverse event rates, neurocognitive events with low levels LDL-C
Economic Benefit for Combo Statin/TG-Specific Tx in T2DM
Greatest cost reduction for statin/TG-specific-treated patients with TG level drop of ≥30 percent
Exenatide, Pioglitazone Effective for Poorly Controlled T2DM
Findings in patients with long-standing poorly controlled type 2 diabetes on metformin, sulfonylurea
Extending Rx Exclusivity Could Boost Study for Rare Diseases
Substantial compensation to many drug manufacturers, especially for top-selling products
